Lv1
60 积分 2025-09-07 加入
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
2个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
2个月前
已完结
Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity
3个月前
已完结
Development and performance evaluation of a novel elastic bacterial nanocellulose/polyurethane small caliber artificial blood vessels
6个月前
已完结
Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches
6个月前
已完结
Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor
7个月前
已完结
Highly selective and oral bioavailable PI3Kγ inhibitor for cancer immunotherapy by targeting myeloid-derived suppressor cells in tumor
7个月前
已关闭
Synthesis and Bio-evaluation of 2-Alkyl Substituted Fluorinated Genistein Analogues against Breast Cancer
8个月前
已完结
皖公网安备34019202002308
